Results 41 to 50 of about 234,176 (365)

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

open access: yesHaematologica, 2016
Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III–IV acute graft-versus-host disease, systemically treated chronic graft-versus-host disease, relapse, and death, is a novel, meaningful composite end point ...
Yoshihiro Inamoto   +16 more
doaj   +1 more source

Chronic graft-versus-host disease and its management in children [PDF]

open access: yes, 2002
Chronic graft-versus-host disease is sometimes a severe, disabling and long-lasting complication of allogeneic hematopoietic stem cell transplantation.
Bakker, J.D.J.   +4 more
core   +1 more source

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

open access: yesHaematologica, 2009
Background A variety of immune pathways can lead to graft-versus-host disease. A better understanding of the type of immune response causing graft-versus-host disease in defined clinical hematopoietic stem cell transplant settings is required to inform ...
Katie Matthews   +10 more
doaj   +1 more source

Influence of grafting on the glass transition temperature of PS thin films [PDF]

open access: yesEur. Phys. J. E (2017) 40: 11, 2017
We present an investigation of the effect of the interaction between a thin polystyrene film and its supporting substrate on its glass transition temperature (Tg). We modulate this interaction by depositing the film on end-tethered polystyrene grafted layers of controlled molecular parameters.
arxiv   +1 more source

Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

open access: yesHaematologica, 2017
Composite endpoints that not only encompass mortality and relapse, but other critical post-transplant events such as graft-versus-host disease, are being increasingly utilized to quantify survival without significant morbidity after allogeneic blood or ...
Shannon R. McCurdy   +24 more
doaj   +1 more source

Cytokines in Graft-versus-Host Disease [PDF]

open access: yesThe Journal of Immunology, 2015
Abstract Graft-versus-host disease (GVHD) is a complication of allogeneic bone marrow transplantation whereby transplanted naive and marrow-derived T cells damage recipient tissue through similar mechanisms to those that allow destruction of malignant cells, the therapeutic intent of bone marrow transplantation.
Henden, Andrea S., Hill, Geoffrey R.
openaire   +4 more sources

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission [PDF]

open access: yes, 2011
BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been established for the treatment of acute myeloid leukemia patients for over 30 years with a cure rate of 50% to 60%.
AMIGO FILHO, José Ulysses   +5 more
core   +2 more sources

Lichenoid variant of chronic cutaneous graft versus host reaction post blood transfusion: A rare event post blood transfusion

open access: yesIndian Journal of Dermatology, 2015
Chronic graft versus host disease (GVHD) is a less frequently seen disease that occurs post solid organ or bone marrow transplantation. Chronic GVHD occurring post blood transfusion is an even more uncommon disease.
Pushpa Kodipalya Ramakrishnaiah   +3 more
doaj   +1 more source

Magnetron plasma mediated immobilization of hyaluronic acid for the development of functional double-sided biodegradable vascular graft [PDF]

open access: yes, 2020
The clinical need for vascular grafts is associated with cardiovascular diseases frequently leading to fatal outcomes. Artificial vessels based on bioresorbable polymers can replace the damaged vascular tissue or create a bypass path for blood flow while stimulating regeneration of a blood vessel in situ.
arxiv   +1 more source

Minors come of age: minor histocompatibility antigens and graft-versus-host disease [PDF]

open access: yes, 2004
Minor histocompatibility antigens (miHA) are responsible for the occurrence of graft-versus-host disease in the setting of a major histocompatibility complex matched sibling allogeneic stem cell transplantation.
Chao, Nelson J
core   +1 more source

Home - About - Disclaimer - Privacy